Accessibility StatementSkip Navigation RALEIGH, N.C., Sept. 30, 2025 /PRNewswire/ --Â First Citizens Bank has named two new Area Executives in South Carolina and Georgia. Justin Rice will oversee the South Carolina Lowcountry region, as well as Savannah, Ga., and JP Connell will be responsible for the Charleston, South Carolina region and surrounding area. Both will lead business, commercial and branch banking operations, serving clients and managing teams in their respective regions. Continue Reading Justi ...

Accessibility StatementSkip Navigation RALEIGH, N.C., Sept. 29, 2025 /PRNewswire/ -- First Citizens Bank today announced that Rod Versteegh, previously Global Business Unit President at DLL, has joined First Citizens as its new Equipment Finance Executive. "A respected veteran of the finance industry with over 30 years of expertise, Rod's leadership will be an incredible asset," said First Citizens Bank President Peter Bristow in announcing the appointment. "Rod has a clear track record of success that we ...

In the current market session, First Citizens BancShares Inc. FCNCA share price is at $1857.49, after a 0.38% spike. Moreover, over the past month, the stock fell by 6.92%, but in the past year, spiked by 1.23%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. How Does First Citizens BancShares P/E Compare to Other Companies?The P/E ratio is used by long-term shareholders to assess the company's market performanc ...

Insider Buying Trends - Insider buying has been below normal in 13 of the past 15 months, with August showing only 26% of purchases compared to sales [3] - Historically, the highest ratio of buys to sells was 2.01 in October 2008 during the Great Recession, indicating that insider buying can signal future recovery [4] Eastman Chemical - Eastman Chemical Co. (EMN) executives, including CEO Mark Costa and CFO McLain William Thomas Jr., made significant purchases of shares on August 27, totaling approximately $502,000 and $252,000 respectively [5] - The stock has fallen 24% this year, impacted by high tariffs on imported materials, yet it has shown profitability for over 30 years [6] - Current valuation is attractive, trading at about nine times earnings and less than one times revenue, suggesting potential for recovery [6] Eli Lilly - Eight executives at Eli Lilly (LLY) bought shares in August, including CEO David Ricks and CFO Lucas Montarce, who spent over $1 million and nearly $495,000 respectively [7] - The stock price has decreased from a high of $942 to around $755, but it trades at a high valuation of 49 times recent earnings and over 12 times revenue, indicating it may be overvalued [8] United Parcel Service - United Parcel Service Inc. (UPS) shares have dropped more than 31% this year, with CEO Carol Tome purchasing over $1 million in August [9] - Despite competitive pressures, UPS maintains a strong return on equity of over 34% and trades for less than 13 times earnings, suggesting potential for future gains [10] First Citizens BancShares - At First Citizens BancShares Inc. (FCNCA), CEO Frank Holding Jr. invested over $1 million in August, alongside four other insiders [11] - The bank has shown improving profits and has consistently achieved a return on assets of 1.0% or better, with the stock trading at a reasonable valuation of 12 times recent earnings [12] Performance of Insider Buying Stocks - Stocks recommended based on insider buying have returned an average of 8.9% over 12 months, underperforming the S&P 500 Total Return Index by 1.8 percentage points [13] - Stocks to avoid despite insider buying have lagged the index by 24 percentage points, while those with ambiguous comments on insider buying have outperformed the index by 14.2 percentage points [14]

Core Insights - Distalmotion and First Citizens Bank's Healthcare Equipment Finance group have launched a financing program aimed at providing hospitals and healthcare providers with lending and leasing solutions for Distalmotion's DEXTER® Robotic Surgery System [1][2]. Company Overview - Distalmotion is a leader in MedTech innovation, headquartered in Lausanne, Switzerland, with U.S. offices in Cleveland, Ohio [2]. - The DEXTER® Robotic Surgery System is designed to make robotic surgery accessible to more patients in outpatient settings, addressing the limitations of traditional soft tissue robots [2]. Financing Program Details - The collaboration between Distalmotion and First Citizens Bank aims to meet the demand for DEXTER® in the outpatient surgery market by offering flexible financing options [3]. - First Citizens Bank's Healthcare Equipment Finance group has extensive experience in healthcare banking and financing, which will support the growth of Distalmotion's innovative technology [4][5]. Market Context - The healthcare industry is increasingly shifting towards an outpatient delivery model, creating a need for financing solutions that cater to this fast-evolving sector [4]. - First Citizens Bank provides a range of lending and leasing solutions to equipment manufacturers and vendors supporting hospitals and ambulatory surgical centers across the U.S. [5].

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ____________________________________________________ FORM 10-Q ____________________________________________________ ☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the quarterly period ended June 30, 2025 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Commission File Number: 001-16715 First Citizens BancShares, Inc. (Exact name of Registrant as ...

RALEIGH, N.C., Aug. 6, 2025 /PRNewswire/ -- Vacations are a top saving priority for Americans despite pressure on household budgets, according to CIT Bank's 2025 Summer Savings Survey conducted by Harris Poll1. The recent survey asked American adults about their savings habits and goals, as well as their plans for summer vacations this year. Though saving up for a rainy day or a new car are also high priorities, planning for their next getaway is top of mind for more Americans — and for good reason. "Saving ...

Key Themes: Fundraising: Fundraising by venture funds in the US is on track to hit $56B this year, a 21% drop from 2024 and the lowest level since 2017. Mega-funds are dominating, leading to larger deal sizes, especially in AI. Among conventional VC fund capital raised in the US over the last three years, more than 36% went to funds at least a billion dollars in size—up from 20% for the period ending six years ago. AI Burn Rate: $5 is burned by the median Series A AI company to gain $1 of new revenue. Burn ...

Core Insights - Silicon Valley Bank (SVB) has partnered with Forge Securities LLC to provide clients with tailored private market liquidity management solutions [1][2] - The partnership aims to address the growing demand for secondary market liquidity as companies remain private longer, facilitating access to capital for scaling and offering liquidity options to employees [2] Group 1: Partnership Details - The referral partnership will enable SVB clients to access Forge's private liquidity solutions, which include managing cap tables and diversifying investor bases [1] - Forge provides a trusted trading platform, proprietary data, and custody services to assist companies and investors in navigating the private market [2][4] Group 2: Market Context - The need for flexible liquidity solutions is increasing, and this partnership is positioned as a response to that demand, supporting long-term growth for companies while meeting liquidity needs [2] - Forge's platform connects private companies with over 19,000 institutional investors looking to invest in private markets [4]

Core Insights - AI-related deal activity in the healthcare sector is thriving despite an overall decline in fundraising, with a 20% decrease in companies not leveraging AI [1][2] - Healthtech is leading AI investment, with AI-related deals doubling over the past 12 months, indicating a strong market trend [2] - China is emerging as a significant player in global biotech, with biopharma licensing deals reaching $3 billion in the first half of 2025, surpassing total spending in 2024 [3] AI Spotlight - Back-office applications are a major focus for AI investment, accounting for 44% of all AI investment in the first half of 2025, aimed at reducing administrative burdens [5] - Half of the funding for diagnostics/tools companies is directed towards those utilizing AI, highlighting the growing importance of AI in this sector [5] Investment by Sector - Healthtech raised a total of $8.2 billion in the first half of 2025, marking the strongest half since H1 2022, with Series B deal sizes reaching $40 million, the highest in five years [5] - In the diagnostics/tools sector, while deal activity has slowed, Series A median pre-money valuations and deal sizes reached five-year highs at $38 million and $14 million, respectively [5] - Medical device investments have remained consistent, totaling between $3 billion and $4 billion every half since 2022, although macroeconomic factors may pose risks [5] Biopharma Insights - Late-stage biopharma companies are favored, with median pre-money valuations for Series C+ at $247 million, compared to $46 million for Series A and $87 million for Series B startups [5]